Drugmakers Plan Price Increases on 350+ Medications Despite Government Pressure
By
JumpCrisscross
Lightly toasted, lightly seasoned, mostly correct.
Summary
Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including COVID, RSV, and shingles vaccines, as well as cancer treatment Ibrance. The median price increase is around 4%, consistent with 2025 levels. This comes despite pressure from the Trump administration for price cuts, and represents an increase from the 250+ drug price hikes announced at the same point last year.
Key quotes
· 3 pulledDrugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts
The number of price increases for 2026 is up from the same point last year, when drugmakers unveiled plans for raises on more than 250 drugs
The median of this year's price hikes is around 4% - in line with 2025
You might also wanna read
Prescription Drug Miebo Costs $800 in U.S. vs. $20 Over-the-Counter in Europe
The article reveals stark differences in drug pricing and accessibility between the U.S. and Europe, using Miebo (EvoTears) as a case study.
statnews.com·5mo ago
White House Launches TrumpRx Direct-to-Consumer Drug Pricing Website
The White House has launched TrumpRx, a direct-to-consumer drug pricing website that allows patients to purchase certain medications at disc
cnbc.com·3mo ago
Study finds private equity firms acquired over 500 autism therapy centers in the past decade
A new study from Brown University researchers reveals that private equity firms acquired over 500 autism therapy centers across the U.S. in
brown.edu·4mo ago
Pfizer's Early 1990s Decision to Abandon Promising GLP-1 Therapy Development
The article reveals previously untold history about early GLP-1 drug development in the late 1980s and early 1990s. The author was part of w
statnews.com·5mo ago
FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company
The article discusses a scandal at the FDA involving a top drug regulator who allegedly used his position to target a former business associ
arstechnica.com·6mo ago
Study Finds UnitedHealth Pays Its Own Physician Practices 17% More Than Competitors
A new study published in Health Affairs reveals that UnitedHealth Group's insurance arm pays its own Optum physician practices 17% more on a
statnews.com·6mo ago